The follicle device developed by the company, Pulsenmore FC, is designed for self-examination of the size of the follicles in women who are in the process of in vitro fertilization and fertility preservation processes, and allows up to 50 scans to measure the size of follicles in the ovaries and endometrial tissue thickness. The move to a home scan using the product is expected to save patients the need to go to women’s health centers in hospitals.
More in-
According to Plassenmore, about 2.5 million in vitro fertilization cycles are currently performed worldwide each year, of which about 50,000 are in Israel. The company predicts that the market potential of the follicular device is about 60% of all women undergoing IVF treatments worldwide. The company, which also develops ultrasound products for heart and kidney patients, received approval from the Ministry of Health about two months ago to market the follicular device it developed.